Featured stories Read our latest thought leadership content on Diagnostic & Interventional Imaging, and Artificial Intelligence. Homepage Guerbet Insights - Any - 2026 ApplyClear Filters New indication in pediatric patients, including term neonates for Guerbet’s half-dose GBCA, Elucirem™ (Gadopiclenol) Injection Read the article Guerbet Visibly Different Read the article Producing solutions in the US for US healthcare providers Read the article Physician Q&A Dr. Bhatia Read the article When you join Guerbet, you’ve chosen a human scale, worldwide leader Read the article
New indication in pediatric patients, including term neonates for Guerbet’s half-dose GBCA, Elucirem™ (Gadopiclenol) Injection Read the article
